Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: MRS Commun. 2017 Sep 12;7(3):442–449. doi: 10.1557/mrc.2017.85

Figure 3.

Figure 3

Metabolic activity (MTT) and cell viability (live/dead images) of GBM10 (a) and GBM12 (b) within GelMA/HAMA hydrogel gradients exposed to first dose of erlotinib. Gradient hydrogels were exposed to single doses of erlotinib of 2 (bottom images), 10 (middle), and 100 μM (top). Scale bar 200 μm.

*P < 0.05 compared with section 1.